Skip to main content

Table 3 Factors related to ECG abnormalities in patients with cirrhosis at pre-transplant evaluation in multivariate logistic regression analysis (n = 186)

From: Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis

ECG abnormality Factor Odds ratio (95% confidence interval)
Prolonged QTc time Possible QT prolonging drug1 5.84 (1.87-18.22)
Alcoholic cirrhosis 2.99 (1.25-7.18)
Age (years) 1.06 (1.01-1.10)
Mean arterial pressure 0.94 (0.90-.0.97)
Propranolol 0.25 (0.1-0.65)
Q wave MELD score (per 1 unit) 1.08 (1.02–1.16)
Age (per year) 1.12 (1.04-1.20)
QRS axis deviation History of arterial hypertension (if yes) 3.14 (1.16-8.47)
Male sex (if yes) 4.40 (1.25-15.43)
ST-segment depression History of arterial hypertension (if yes) 7.00 (1.30-37.84)
Cholestatic liver disease (if yes) 6.10 (1.24-30.15)
Any feature of CAD 2 MELD score (per 1 unit) 1.08 (1.02-1.14)
Age (per year) 1.05 (1.01-1.09)
Viral liver disease (if yes) 0.26 (0.08-0.84)
  1. GFR, Glomerular filtration rate; MELD, Model of end stage liver disease; CAD, Coronary artery disease.
  2. 1Flouroquinolones - 19, Selective serotonin re-uptake inhibitors - 10, Quinine - 6, Prepulside - 1.
  3. 2Q wave, T wave inversion and/or ST-depression (17, 18).